HeyJaredAmy McLean
- Indexed articles, last 90 days
- 18
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Medicalnewstoday
- Top 10K sites
- Earliest in this view
- Jul 4, 2026
Latest articles
Type 2 diabetes: What kind of exercise helps lower risk? (opens the original)
Read excerpt
Physical inactivity is a known risk factor for type 2 diabetes. There are around 40 million people in the United States with some type of diabetes, and type 2 diabetes accounts for around 90% to 95% of all diabetes cases. Type 2 diabetes can develop if the body does not make enough insulin or if it does not respond to insulin correctly. Overweight, age, and conditions such as prediabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) are also risk factors. New research publ
Heart attack: At-home exercise rehab reduces risk in people with CVD (opens the original)
Read excerpt
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Around 85% of 19.8 million CVD-related deaths in 2022 were due to heart attack (myocardial infarction) or stroke, according to the World Health Organization. A recently updated Cochrane review published in September examined whether cardiac rehabilitation could impact health-related quality of life, disease status, and mortality in people with CVD. It was determined that cardiac rehabilitation helped reduce the relative ris
Cancer: Blood test trends may predict risk better than single test (opens the original)
Read excerpt
In primary care, blood test abnormalities can be one factor considered in cancer risk assessments. However, they generally primarily focus on whether individual test results are abnormal at a specific moment in time. A study published in September in PLOS Medicine suggests that monitoring changes in blood test results over time may be more beneficial for assessing cancer risk than relying on information from the most recent blood test only. The researchers focused on 275,205 patients presenting
AI could offer more precise breast cancer recurrence risk, study finds (opens the original)
Read excerpt
Hormone receptor-positive, HER2-negative (HR+/HER2â) breast cancer is the most common type of breast cancer. Over half of distant recurrence cases occur five years or more after completing treatment for HR+/HER2â node-negative breast cancer. According to the authors of a study published in August in npj breast cancer, HR+/HER2- breast cancer âaccounts for about 60% of all breast cancer deaths due to high prevalence and persistent recurrence risk beyond 5 years.â The 21-gene Recurrence Sc
AI could offer more precise breast cancer recurrence risk, study finds (opens the original)
Read excerpt
Hormone receptor-positive, HER2-negative (HR+/HER2â) breast cancer is the most common type of breast cancer. Over half of distant recurrence cases occur five years or more after completing treatment for HR+/HER2â node-negative breast cancer. According to the authors of a study published in August in npj breast cancer, HR+/HER2- breast cancer âaccounts for about 60% of all breast cancer deaths due to high prevalence and persistent recurrence risk beyond 5 years.â The 21-gene Recurrence Sc
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 10K sites
For Medicalnewstoday, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.